Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease

por Millier, Aurélie, Supiot, Romain, Benyounes, Kelly, Machuron, Valérie, Le Lay, Katell, Sivignon, Marine, Leboucher, Claire, Blein, Cécile, Raffi, François
Publicado 2022

Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France

por Squara, Pierre-Alexandre, Luu, Vinh-Phuc, Pérol, David, Coudert, Bruno, Machuron, Valérie, Bachot, Camille, Samelson, Laurence, Florentin, Virginie, Pinguet, Jean-Marc, Ben Hadj Yahia, Béchir
Publicado 2022